JPMorgan Downgrades Leidos to Neutral From Overweight, Price Target is $142
JPMorgan downgraded Leidos to 'Neutral' from 'Overweight' and set a price target of $142. The stock has fallen 2.69% in 5 days and 6.80% year-to-date, with a 37.06% decline since 2026-10-07.
How this was made
The 30-second read
Why it matters
The downgrade may trigger short‑term sell‑offs, but longer‑term fundamentals could remain intact if new contracts materialize.
Market read
Analyst rating changes are a common catalyst for short‑term price moves in mid‑cap stocks like Leidos.
What to watch
Potential upcoming contract awards or cost‑saving initiatives that could offset the downgrade were not discussed.
Background
JPMorgan's research team adjusted its stance on Leidos, reflecting revised expectations for earnings and valuation.
Market effects
Defense and government‑contracting sector may see slight pullback as a major player receives a downgrade.
U.S. equities could experience modest downside in related aerospace/defense stocks.
Limited; impact confined to U.S. defense contractors and investors tracking analyst sentiment.
Counterpoint
Some investors may view the downgrade as an overreaction if Leidos' contract pipeline remains strong.
Key entities
- companyLeidos Holdings, Inc.
U.S. defense and intelligence contractor.
- analystJPMorgan
Investment bank providing the downgrade and price target.
